Kabulski Galen M, Northup Amanda, Wiggins Barbara S
Department of Pharmacy Services, Medical University of South Carolina, Charleston, SC, USA.
College of Pharmacy, Medical University of South Carolina, Charleston, SC, USA.
J Innov Card Rhythm Manag. 2019 Aug 15;10(8):3777-3784. doi: 10.19102/icrm.2019.100804. eCollection 2019 Aug.
Infections related to cardiac implantable electronic device (CIED) placement are associated with poor clinical outcomes. As such, preprocedural prophylactic antibiotic therapy is indicated for all patients prior to device insertion. However, the available data are less clear on the impact of postprocedural antibiotic therapy on rates of CIED infection when used in addition to preprocedural therapy. This is single-center, retrospective cohort study of 913 patients who underwent CIED-related procedures between October 2010 and August 2014 sought to compare the rate of CIED infections in patients receiving only preprocedural antibiotics with those receiving both preprocedural and postprocedural antibiotics. Univariate analysis was used to detect independent risk factors for CIED infection. After excluding patients receiving concomitant antibiotics for other conditions, those undergoing CIED extraction alone, and those with a lack of follow-up data and/or adequate documentation of clinical encounters, 569 patients were identified for inclusion in the final analysis. The majority of patients who received postprocedural antibiotics received three to five days of therapy, with the most common antibiotic used being cephalexin. There was no statistically significant difference in the incidence of infection between patients who did and did not receive postoperative antibiotics (4.5% versus 6.1%; p = 0.398). In a multivariate analysis, the use of postprocedural antibiotic therapy was not a significant risk factor for infection (adjusted odds ratio: 0.692; 95% confidence interval: 0.314-1.525; p = 0.361). It is therefore reasonable to withhold prescribing postoperative antibiotics in patients following CIED implantation. Individualized risk factor evaluation of patient comorbidities and procedural characteristics may be needed to aid in determining whether postoperative antibiotics are reasonable in different patients. The validity of these findings is contingent on further confirmation via a prospective, randomized clinical trial.
与心脏植入式电子设备(CIED)植入相关的感染与不良临床结局相关。因此,所有患者在设备植入前均需进行术前预防性抗生素治疗。然而,关于术后抗生素治疗在术前治疗基础上使用时对CIED感染率的影响,现有数据尚不清楚。这是一项单中心回顾性队列研究,研究对象为2010年10月至2014年8月期间接受CIED相关手术的913例患者,旨在比较仅接受术前抗生素治疗的患者与接受术前和术后抗生素治疗的患者的CIED感染率。采用单因素分析检测CIED感染的独立危险因素。在排除因其他疾病接受联合抗生素治疗的患者、仅接受CIED取出术的患者以及缺乏随访数据和/或临床诊疗充分记录的患者后,确定569例患者纳入最终分析。大多数接受术后抗生素治疗的患者接受了3至5天的治疗,最常用的抗生素是头孢氨苄。接受和未接受术后抗生素治疗的患者之间感染发生率无统计学显著差异(4.5%对6.1%;p = 0.398)。在多因素分析中,术后抗生素治疗的使用不是感染的显著危险因素(调整后的优势比:0.692;95%置信区间:0.314 - 1.525;p = 0.361)。因此,对于CIED植入术后的患者,不给予术后抗生素处方是合理的。可能需要对患者合并症和手术特征进行个体化危险因素评估,以帮助确定术后抗生素在不同患者中是否合理。这些发现的有效性取决于通过前瞻性随机临床试验的进一步证实。